股票 › TSHA
泰莎基因治疗 TSHA
美股市值排名 #2991
$4.33 +$0.24 (+5.87%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $4.33 0.00%
开盘$4.16
昨收$4.09
当日区间$4.14 – $4.45
成交量3.18M
市值$1.41B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00-100.0% YoY
营业利润-$50.78M-89.8% YoY
净利润-$46.64M-73.5% YoY
摊薄每股收益-$0.13-44.4% YoY
自由现金流-$40.42M-100.3% YoY
经营现金流-$40.43M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
营业利润率-2,854.9%
净利率-2,728.0%
净资产收益率-47.1%
资产收益率-37.2%
投入资本回报率-42.7%
流动比率17.76
负债/资产比率17.7%
现金及投资$455.41M
总负债$55.55M
净现金（净负债）$399.86M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $0.00 | $0.00 | – | – | $0.00 |
| 营业总收入 | $0.00 | $0.00 | $9.77M | $5.49M | $0.00 |
| 营业费用 | $50.78M | $43.49M | $120.27M | $33.79M | $34.02M |
| 销售及管理费用 | $12.15M | $9.68M | $33.87M | $8.83M | $8.28M |
| -管理费用 | $12.15M | $9.68M | $33.87M | $8.83M | $8.28M |
| 研发费用 | $38.64M | $33.81M | $86.40M | $24.95M | $25.75M |
| 营业利润 | -$50.78M | -$43.49M | -$110.50M | -$28.30M | -$34.02M |
| 非经营性利息净收入（支出） | $2.32M | $2.58M | $9.16M | $2.86M | $3.15M |
| 非经营性利息收入 | $2.33M | $2.59M | $9.22M | $2.87M | $3.17M |
| 非经营性利息支出 | $6,000.00 | $9,000.00 | $63,000.00 | $12,000.00 | $15,000.00 |
| 其他收入（支出） | $1.82M | -$1.50M | -$7.66M | -$2.41M | -$1.86M |
| 特殊收益（费用） | $3.43M | – | $0.00 | $0.00 | $0.00 |
| -减：其他特殊支出 | -$3.43M | – | – | – | – |
| 其他非经营性收入（支出） | -$1.61M | -$1.50M | -$6.46M | -$1.67M | -$1.57M |
| 税前利润 | -$46.64M | -$42.41M | -$109.00M | -$27.85M | -$32.73M |
| 净利润 | -$46.64M | -$42.41M | -$109.00M | -$27.85M | -$32.73M |
| 持续经营利润 | -$46.64M | -$42.41M | -$109.00M | -$27.85M | -$32.73M |
| 归属母公司净利润 | -$46.64M | -$42.41M | -$109.00M | -$27.85M | -$32.73M |
| 归属普通股股东净利润 | -$46.64M | -$42.41M | -$109.00M | -$27.85M | -$32.73M |
| 基本每股收益 | -$0.13 | -$0.12 | -$0.34 | -$0.08 | -$0.09 |
| 摊薄每股收益 | -$0.13 | -$0.12 | -$0.34 | -$0.08 | -$0.09 |
| 证券出售收益 | – | – | -$1.20M | -$736,000.00 | -$292,000.00 |
| -减：资本性资产减值 | – | – | $0.00 | $0.00 | $0.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $470.43M | $300.35M | $343.32M | $343.32M | $316.55M |
| 流动资产合计 | $461.43M | $282.25M | $324.65M | $324.65M | $299.95M |
| 现金及现金等价物与短期投资 | $455.41M | $276.58M | $319.77M | $319.77M | $297.34M |
| -现金及现金等价物 | $455.41M | $276.58M | $319.77M | $319.77M | $297.34M |
| 预付资产 | $5.07M | $4.02M | $3.43M | $3.43M | $1.65M |
| 受限现金 | $0.00 | $449,000.00 | $449,000.00 | $449,000.00 | $449,000.00 |
| 一年内递延资产 | $110,000.00 | $195,000.00 | $195,000.00 | $195,000.00 | $57,000.00 |
| 其他流动资产 | $851,000.00 | $1.01M | $802,000.00 | $802,000.00 | $456,000.00 |
| 非流动资产合计 | $9.00M | $18.10M | $18.67M | $18.67M | $16.60M |
| 固定资产净值 | $8.73M | $15.61M | $16.18M | $16.18M | $14.27M |
| -固定资产原值 | $13.98M | $20.58M | $20.86M | $20.86M | $18.65M |
| -累计折旧 | -$5.25M | -$4.97M | -$4.68M | -$4.68M | -$4.39M |
| 其他非流动资产 | $270,000.00 | $2.50M | $2.50M | $2.50M | $2.34M |
| 负债合计 | $83.17M | $88.41M | $96.38M | $96.38M | $97.57M |
| 流动负债合计 | $25.98M | $20.10M | $26.55M | $26.55M | $28.63M |
| 应付款 | $9.16M | $4.56M | $6.28M | $6.28M | $5.44M |
| -应付账款 | $9.16M | $4.56M | $6.28M | $6.28M | $5.44M |
| 一年内应计费用 | $9.92M | $9.94M | $8.21M | $8.21M | $9.04M |
| 短期债务及融资租赁负债 | $1.16M | $1.82M | $1.87M | $1.87M | $1.67M |
| -一年内到期融资租赁负债 | $1.16M | $1.82M | $1.87M | $1.87M | $1.67M |
| 其他流动负债 | $355,000.00 | $784,000.00 | $777,000.00 | $777,000.00 | $1.65M |
| 非流动负债合计 | $57.19M | $68.31M | $69.83M | $69.83M | $68.93M |
| 长期债务及融资租赁负债 | $55.55M | $66.73M | $68.28M | $68.28M | $67.36M |
| -长期债务 | $49.26M | $48.96M | $50.11M | $50.11M | $50.85M |
| -长期融资租赁负债 | $6.29M | $17.77M | $18.17M | $18.17M | $16.51M |
| 其他非流动负债 | $1.64M | $1.58M | $1.55M | $1.55M | $1.58M |
| 股东权益合计 | $387.27M | $211.94M | $246.94M | $246.94M | $218.99M |
| 股东权益 | $387.27M | $211.94M | $246.94M | $246.94M | $218.99M |
| 股本 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 |
| -普通股 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $1.19B | $964.67M | $958.43M | $958.43M | $903.58M |
| 留存收益 | -$800.35M | -$753.71M | -$711.30M | -$711.30M | -$683.45M |
| 不影响留存收益的损益 | $769,000.00 | $985,000.00 | -$192,000.00 | -$192,000.00 | -$1.14M |
| 一年内递延负债 | – | – | $0.00 | $0.00 | $5.49M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$40.43M | -$40.88M | -$93.09M | -$26.72M | -$24.17M |
| 持续经营经营活动现金流净额 | -$40.43M | -$40.88M | -$93.09M | -$26.72M | -$24.17M |
| 持续经营净利润 | -$46.64M | -$42.41M | -$109.00M | -$27.85M | -$32.73M |
| 折旧、折耗与摊销 | $291,000.00 | $295,000.00 | $1.15M | $299,000.00 | $286,000.00 |
| 其他非现金项目 | -$4.66M | $344,000.00 | $5.63M | $3.64M | $673,000.00 |
| 营运资金变动 | $4.77M | -$4.65M | -$5.37M | -$7.07M | $4.03M |
| -预付资产变动 | -$645,000.00 | -$794,000.00 | -$1.73M | -$2.14M | $971,000.00 |
| -应付账款及应计费用变动 | $5.42M | -$3.86M | $6.14M | $548,000.00 | $3.06M |
| 投资活动现金流净额 | $1,000.00 | -$3.02M | -$604,000.00 | -$247,000.00 | -$48,000.00 |
| 持续经营投资活动现金流净额 | $1,000.00 | -$3.02M | -$604,000.00 | -$247,000.00 | -$48,000.00 |
| 固定资产购置及出售净额 | $1,000.00 | -$24,000.00 | -$738,000.00 | -$250,000.00 | -$108,000.00 |
| 无形资产购置及出售净额 | $0.00 | -$3.00M | – | – | – |
| 筹资活动现金流 | $216.66M | $711,000.00 | $274.59M | $49.56M | $8.80M |
| 持续经营筹资活动现金流净额 | $216.66M | $711,000.00 | $274.59M | $49.56M | $8.80M |
| 股票期权行使所得 | $441,000.00 | $692,000.00 | $1.38M | $1.02M | $281,000.00 |
| 其他筹资费用净额 | $75,000.00 | $19,000.00 | -$337,000.00 | -$57,000.00 | -$271,000.00 |
| 期末现金余额 | $455.57M | $279.34M | $322.53M | $322.53M | $299.94M |
| 现金净变动 | $176.23M | -$43.19M | $180.90M | $22.59M | -$15.42M |
| 期初现金余额 | $279.34M | $322.53M | $141.64M | $299.94M | $315.36M |
| 自由现金流 | -$40.42M | -$43.90M | -$93.83M | -$26.97M | -$24.27M |
| 持续经营损益 | – | – | $1.20M | $736,000.00 | $292,000.00 |
| -其他营运资金变动 | – | – | -$9.77M | -$5.49M | $0.00 |
| 其他投资变动净额 | – | – | $134,000.00 | $3,000.00 | $60,000.00 |
| 债务发行及偿还净额 | – | – | $9.24M | $0.00 | – |
| 普通股发行净额 | – | – | $264.31M | $48.59M | -$454,000.00 |
暂无评论——快来第一个聊聊 TSHA。
登录后参与讨论。